被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Safety advisory: ISHOU Fulin Ruan Jiaonang capsules contain the undeclared substance sibutramine (English Only) |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled ISHOU Fulin Ruan Jiaonang capsules and found that the capsules contain the undeclared substance sibutramine. Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). Sibutramine was withdrawn from the Australian market in Oct 2010 after a study showed an increased risk of major cardiac events. Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/ishou-fulin-ruan-jiaonang-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Feb 25, 2019
Issued at HKT 15:00
|
| |
